Aptamers Market to Grow at 7.11% through 2030F
The growing prevalence of chronic
and rare diseases is expected to drive the growth of Global Aptamers Market in
the forecast period, 2026-2030
According to TechSci Research report, “Aptamers
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F”, Global Aptamers Market was valued at USD 2.05 billion in 2024 and is expected to reach USD 3.07 billion by 2030 with a CAGR of 7.11% during the forecast period. This can be ascribed to the growing usage of
aptamers in different field such as research, diagnostics, medicine, among
others. The growing demand for low-cost product and increasing research
activities in the pharmaceutical and biotechnology industries is expected to
boost the growth of the market during the forecasted period. Also, rapid rise
in the infectious diseases across the globe along with grow will further
enhance the demand for the aptamers market in the forecasted period. Besides,
growing research activities to evaluate the mechanism of action of nucleic acid
aptamers to treat age related macular degeneration is further expected to
support the market growth during the forecast period. Also, growing
advancements in the generation, purification and drug delivery for killing the
target cells have attracted the attention of many researchers towards aptamers
due to competitive advantages associated with them will further drive the
growth of the market during the forecasted period.
However, the lack of proper guidelines on molecular
development along with shortage of trained and expert professionals may slow
down the growth of the global aptamers market in the forecast period. Also, the
low adoption rates and lack of awareness about the latest technologies in
middle- and low-income countries may hamper the growth of the market during the
forecast period. The improper regulatory structure and problem regarding the
efficiency and safety standards over clinical studies can further restrict the
growth of the global aptamers market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Aptamers Market"
Aptamers market can be segmented by type, technology,
application, end user and region.
Based on End user, Pharmaceutical and biotechnology companies is the Fastest Growing Segment in the
aptamers market due to their critical role in developing advanced diagnostic
and therapeutic solutions. These companies are at the forefront of innovation,
investing heavily in research and development to explore new technologies that
improve patient outcomes. Aptamers, with their high specificity, stability, and
lower immunogenicity compared to antibodies, are highly attractive for drug
development, biomarker discovery, and molecular imaging—core areas of focus for
these industries. The infrastructure and expertise available within
pharmaceutical and biotech firms enable rapid screening, synthesis, and
modification of aptamers for targeted applications. Their capacity to conduct
preclinical and clinical trials further accelerates aptamer commercialization.
Collaborations with academic institutions and startups also strengthen their
innovation pipeline. As the demand for personalized medicine and targeted
therapies grows, these companies continue to lead the charge by integrating
aptamers into precision treatment strategies. Their strategic investments and
regulatory experience solidify their dominant position in the global market.
Based on region, Asia-Pacific is the fastest-growing
region in the global aptamers market due to a combination of economic,
scientific, and healthcare developments. The region is witnessing a surge in
biotechnology and pharmaceutical research, supported by increasing government
and private investments. Countries like China, India, South Korea, and Japan
are actively expanding their life sciences infrastructure, which creates a
favorable environment for aptamer research and applications. The growing
prevalence of chronic diseases, an aging population, and rising demand for
affordable and targeted therapies are driving the need for innovative
diagnostic and therapeutic tools. Aptamers, known for their high specificity,
low production cost, and versatility, are gaining traction in addressing these
healthcare needs. Academic institutions and research organizations across the
region are contributing significantly to aptamer development, often
collaborating with global and local industry players. Favorable regulatory
reforms and the growing availability of skilled scientific talent further
accelerate research and commercialization efforts. Asia-Pacific also offers
cost advantages in clinical trials and manufacturing, attracting global
companies to invest and expand in the region. This combination of demand
growth, infrastructure development, and investment momentum positions
Asia-Pacific as a dynamic hub for aptamer innovation, fueling its rapid growth
in the global market.
Major
companies operating in the global aptamers market are:
- Aptamer Group
- Raptamer Discovery Group
- Somalogic Inc.
- Aptamer Sciences, Inc.
- Aptagen LLC.
- Maravai Lifesciences.
- Kaneka Corporation.
- Neoventures Biotechnology Inc.
- Aptus Biotech.
- Base Pair Biotechnologies.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“North America was expected to dominate in the global
aptamers market due to the growing prevalence of chronic diseases across the
region especially in the United States. The well-established healthcare and
pharmaceutical infrastructure within the region is further supporting the
growth of aptamers market. Similarly, the growing interest of research
laboratories in the aptamers fields is further expected to support the market
growth during the forecast period.” said Mr. Karan Chechi, Research Director
of TechSci Research, a research-based global management consulting firm.
“Aptamers Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (DNA
Aptamers, XNA Aptamers, RNA Aptamers), By Technology (SELEX, Others), By
Application (Therapeutics Development, Research & Development, Diagnostics,
Others), By End User (Pharmaceutical & Biotechnology Companies, Academic &
Research Institutions, Contract Research Organizations, Others), By
Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global aptamers market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision-makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in the global aptamers market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com